ASX Stocks That May Be Trading Below Their Estimated Value In November 2024

Simply Wall St.
2024-11-18

The Australian market has shown resilience with the ASX200 closing up 0.18% at 8,300 points, buoyed by strong performances in the Staples and Utilities sectors. In this environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors seeking to capitalize on potential market inefficiencies and sector-specific strengths.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Name Current Price Fair Value (Est) Discount (Est)
Mader Group (ASX:MAD) A$6.68 A$13.22 49.5%
Telix Pharmaceuticals (ASX:TLX) A$22.78 A$44.45 48.8%
MLG Oz (ASX:MLG) A$0.57 A$1.12 49.2%
Atlas Arteria (ASX:ALX) A$4.89 A$9.44 48.2%
Ingenia Communities Group (ASX:INA) A$4.92 A$9.33 47.2%
Vault Minerals (ASX:VAU) A$0.325 A$0.64 49.5%
Millennium Services Group (ASX:MIL) A$1.145 A$2.24 48.9%
Audinate Group (ASX:AD8) A$8.82 A$17.59 49.9%
Energy One (ASX:EOL) A$5.94 A$10.77 44.8%
FINEOS Corporation Holdings (ASX:FCL) A$2.03 A$3.83 47%

Click here to see the full list of 39 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Atlas Arteria

Overview: Atlas Arteria Limited owns, develops, and operates toll roads with a market capitalization of A$7.12 billion.

Operations: The company's revenue is primarily derived from its toll road operations, with contributions of A$1.70 billion from APRR, A$36.90 million from ADELAC, A$25.10 million from Warnow Tunnel, A$128.90 million from Chicago Skyway, and A$115 million from Dulles Greenway.

Estimated Discount To Fair Value: 48.2%

Atlas Arteria is trading at A$4.91, significantly below its estimated fair value of A$9.44, indicating it may be undervalued based on cash flows. Despite a forecasted revenue growth of 19.6% per year, which outpaces the Australian market's 5.7%, its dividend yield of 8.15% isn't well covered by earnings or free cash flows. Recent leadership changes with Hugh Wehby as CEO may impact strategic direction positively in the infrastructure sector.

  • Our growth report here indicates Atlas Arteria may be poised for an improving outlook.
  • Click to explore a detailed breakdown of our findings in Atlas Arteria's balance sheet health report.
ASX:ALX Discounted Cash Flow as at Nov 2024

FINEOS Corporation Holdings

Overview: FINEOS Corporation Holdings plc develops and sells enterprise claims and policy management software for the employee benefits and life, accident, and health insurance industries worldwide, with a market cap of A$656.34 million.

Operations: The company's revenue primarily stems from its software and programming segment, which generated €122.24 million.

Estimated Discount To Fair Value: 47%

FINEOS Corporation Holdings is trading at A$2.03, significantly below its estimated fair value of A$3.83, reflecting potential undervaluation based on cash flows. Despite a net loss of EUR 5.32 million for the first half of 2024, FINEOS expects revenue growth to outpace the Australian market at 9.7% annually and projects profitability within three years. Recent client acquisition with Voya Financial underscores its strong position in the insurance software sector despite being dropped from the S&P Global BMI Index.

  • Our expertly prepared growth report on FINEOS Corporation Holdings implies its future financial outlook may be stronger than recent results.
  • Click here and access our complete balance sheet health report to understand the dynamics of FINEOS Corporation Holdings.
ASX:FCL Discounted Cash Flow as at Nov 2024

Nuix

Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including Asia Pacific, the Americas, Europe, the Middle East, and Africa, with a market cap of A$2.02 billion.

Operations: The company's revenue primarily comes from its Software & Programming segment, which generated A$220.62 million.

Estimated Discount To Fair Value: 13%

Nuix Limited, trading at A$6.20, is priced below its estimated fair value of A$7.13, suggesting potential undervaluation based on cash flows. The company recently turned profitable and forecasts robust earnings growth of 59.6% annually over the next three years, outpacing the Australian market average. However, shareholders faced dilution last year and Return on Equity is projected to be low at 11.9% in three years despite revenue growth surpassing market rates.

  • The growth report we've compiled suggests that Nuix's future prospects could be on the up.
  • Unlock comprehensive insights into our analysis of Nuix stock in this financial health report.
ASX:NXL Discounted Cash Flow as at Nov 2024

Summing It All Up

  • Click through to start exploring the rest of the 36 Undervalued ASX Stocks Based On Cash Flows now.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Ready To Venture Into Other Investment Styles?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:ALX ASX:FCL and ASX:NXL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10